Tandem Diabetes Care, Inc. (LON:0M0F)
London flag London · Delayed Price · Currency is GBP · Price in USD
21.19
+0.37 (1.78%)
At close: Dec 12, 2025

Tandem Diabetes Care Statistics

Total Valuation

LON:0M0F has a market cap or net worth of GBP 1.09 billion. The enterprise value is 1.19 billion.

Market Cap1.09B
Enterprise Value 1.19B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date Feb 26, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 67.80M
Shares Outstanding n/a
Shares Change (YoY) +2.23%
Shares Change (QoQ) +0.90%
Owned by Insiders (%) 1.07%
Owned by Institutions (%) 104.82%
Float 62.04M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.45
PB Ratio 10.98
P/TBV Ratio 10.98
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -7.85
EV / Sales 1.57
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -63.50

Financial Position

The company has a current ratio of 2.44, with a Debt / Equity ratio of 3.42.

Current Ratio 2.44
Quick Ratio 1.76
Debt / Equity 3.42
Debt / EBITDA n/a
Debt / FCF -18.08
Interest Coverage -11.31

Financial Efficiency

Return on equity (ROE) is -109.73% and return on invested capital (ROIC) is -8.36%.

Return on Equity (ROE) -109.73%
Return on Assets (ROA) -5.93%
Return on Invested Capital (ROIC) -8.36%
Return on Capital Employed (ROCE) -13.98%
Revenue Per Employee 282,697
Profits Per Employee -57,091
Employee Count2,650
Asset Turnover 1.10
Inventory Turnover 3.25

Taxes

Income Tax -1.17M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -38.08% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -38.08%
50-Day Moving Average 17.24
200-Day Moving Average 17.09
Relative Strength Index (RSI) 64.78
Average Volume (20 Days) 1,047

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 4.14

Income Statement

In the last 12 months, LON:0M0F had revenue of GBP 749.15 million and -151.29 million in losses. Loss per share was -2.27.

Revenue749.15M
Gross Profit 398.76M
Operating Income -64.72M
Pretax Income -152.46M
Net Income -151.29M
EBITDA -51.76M
EBIT -64.72M
Loss Per Share -2.27
Full Income Statement

Balance Sheet

The company has 237.40 million in cash and 337.89 million in debt, giving a net cash position of -100.49 million.

Cash & Cash Equivalents 237.40M
Total Debt 337.89M
Net Cash -100.49M
Net Cash Per Share n/a
Equity (Book Value) 98.92M
Book Value Per Share 1.46
Working Capital 271.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.54 million and capital expenditures -12.15 million, giving a free cash flow of -18.69 million.

Operating Cash Flow -6.54M
Capital Expenditures -12.15M
Free Cash Flow -18.69M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 53.23%, with operating and profit margins of -8.64% and -20.20%.

Gross Margin 53.23%
Operating Margin -8.64%
Pretax Margin -20.35%
Profit Margin -20.20%
EBITDA Margin -6.91%
EBIT Margin -8.64%
FCF Margin n/a

Dividends & Yields

LON:0M0F does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.23%
Shareholder Yield -2.23%
Earnings Yield -13.93%
FCF Yield -1.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

LON:0M0F has an Altman Z-Score of 0.61 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.61
Piotroski F-Score 3